Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency

OBJECTIVE: This post-hoc analysis compared the lipid-altering efficacy of Ezetimibe/Simvastatin 10/20 mg (EZ/Simva) versus Rosuvastatin 10 mg (Rosuva) in patients stratified by statin potency/dose prior to randomization. METHODS: Patients with elevated low-density lipoprotein cholesterol (LDL-C) des...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Viigimaa, Margus, Vaverkova, Helena, Farnier, Michel, Averna, Maurizio, Missault, Luc, Hanson, Mary E, Dong, Qian, Shah, Arvind, Brudi, Philippe
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2010
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2992529/
https://ncbi.nlm.nih.gov/pubmed/21050476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-511X-9-127
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi